“…The minor ginsenosides, such as F2, Compound-K (C-K), Compound-C-Mc (C-Mc), Compound-Y (C-Y), Rg3, Rg2, Rh2, Rh1, and F1, which are present at a low concentration in red ginseng and wild ginseng, can be produced by hydrolyzing the sugar moieties of major ginsenosides, including Rb1, Rb2 , Rc, Rd, Rf, Re, and Rg1 [8–10] . Many studies show that the minor ginsenosides have good pharmacological activities [11] , such as anticarcinogenic [12–14] , immunomodulatory, anti-inflammatory, antiallergic [15] , antiatherosclerotic, antihypertensive, antiaging, and antidiabetic [16] effects as well as antistress activity and effects on the central nervous system [11,17,18] . Therefore, ginsenoside sugar chains are closely related to their biological activity, and the modification of their sugar chains may markedly change their pharmacological activity.…”